Livtencity
Active Ingredient(s): MaribavirFDA Approved: * November 23, 2021
Pharm Company: * TAKEDA PHARMS USA
Category: Antiviral
Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV).[1][2] The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue.[2] Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication.[2] Maribavir was approved f... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.